The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Boston Scientific will purchase Ajax Health's Cortex and its OptiMap system to guide physicians performing AFib-treating ...

Care Medical has entered into a strategic partnership with Boston Scientific aimed at raising awareness and providing ...

The company’s cardiology, peripheral interventions and electrophysiology businesses are based in the state. Last week, Boston Scientific announced the U.S. Food and Drug Administration approved ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Cardiology net sales rose 29% year-over-year to $2.13 billion, ahead of the $2 billion projection. For the fourth quarter of 2024, Boston Scientific expects EPS to range between $0.64 and $0.66 ...

Please go ahead. Thank you, Alan, and welcome, everyone, on the webcast. We have our Cardiology leadership team here today, including Joe Fitzgerald, Executive Vice President and Group President ...

Boston Scientific reported 29.2% growth for cardiology products and 11.8% growth in peripheral interventions. MedSurg segment revenues increased 10.3% to $1.48 billion (10.4% operationally and 7.7 ...

Boston Scientific Corporation reported 19.3% y ... The Cardiovascular Segment, which includes Cardiology and Peripheral Interventions, grew at an astounding 25% y/y driven mostly by sales in ...

The upcoming report from Boston Scientific (BSX ... The consensus estimate for 'Net Sales- Cardiovascular- Cardiology- Worldwide' stands at $2.00 billion. The estimate suggests a change of ...